Navigation Links
Symmetry Medical Announces Restructuring
Date:12/18/2009

WARSAW, Ind., Dec. 18 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today a restructuring that includes a facility consolidation and other staff reductions designed to increase operational efficiency and drive annualized cost savings. The restructuring is designed to position the Company for continued market leadership during the anticipated orthopedic industry recovery.

As part of the restructuring, the Company will consolidate its Auburn, ME operations into other existing Symmetry Medical facilities by the middle of 2010. The consolidation will include the transfer of current production capacity, including equipment and machinery. The Company is taking steps to minimize any disruptions, and expects to continue to provide a seamless high level of quality and service to its customers during the consolidation.

The restructuring, once complete, is expected to generate an ongoing annualized cost savings of approximately $3.4 million, on a pre-tax basis. The total one-time cost of these actions is anticipated to be in the range of $2.4 to $2.8 million.

As a result of these actions, the Company will incur a fourth quarter 2009 restructuring charge of between $1.8 million and $2.2 million, on a pre-tax basis, consisting of primarily of severance costs and impairment of property, plant and equipment.

The Company also anticipates approximately $0.4 million of related expense in 2010 resulting from relocation and equipment moving expenses.

In addition to the restructuring charges noted above, the Company is currently evaluating long-lived intangible assets including goodwill related to the Auburn, ME operations, which were acquired in May 2006, for potential impairment. The Company will communicate any required non-cash charges related to these assets when the analysis is completed.

Excluding the above one-time charges, the Company is reconfirming its latest 2009 full year guidance of earnings per diluted share in the range of $0.63 to $0.68.

Brian Moore, President and Chief Executive Officer of Symmetry Medical, stated, "These decisions are difficult under any circumstances, and we recognize the personal impact they have on those dedicated employees who have made contributions to the success of our business. We are committed to treating them fairly and with respect throughout this process."

Mr. Moore continued, "These initiatives reflect our continuing efforts to streamline our cost structure and improve operational efficiencies throughout our Total Solutions® global network. We believe these strategic decisions are being made at an opportune time to further strengthen profitability and help us prepare for the anticipated resurgence of growth in the orthopedic industry. We remain well positioned to respond to increased global customer demand and believe this consolidation will further strengthen our competitive position in the industry."

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading independent provider of implants and related instruments and cases to the orthopaedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including arthroscopy, dental, laparoscopy, osteobiologic and endoscopy sectors and provides limited specialized products and services to non-healthcare markets, such as the aerospace market.

Forward-Looking Statements

Statements in the press release regarding Symmetry Medical Inc.'s business which are not historical facts may be "forward-looking statements" that involve risks and uncertainties, within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictive in nature and are frequently identified by the use of terms such as "may," "might," "will," "should," "expect," "believe," "anticipate," "plan," "estimate," "intend," and similar words indicating possible future expectations, events or actions. Such predictive statements are not guarantees of future performance, and actual outcomes and results could differ materially from our current expectations. We refer you to the "Risk Factors" and "Forward Looking-Statements" sections in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission as well as the Company's other filings with the SEC, which are available on the SEC's Web site at www.sec.gov.


    Contact:
    Symmetry Medical Inc.
    Fred L. Hite
    Senior Vice President
    Chief Financial Officer
    (574) 371-2218

    Investors:
    The Ruth Group
    Nick Laudico/R.J. Pellegrino
    (646) 536-7030/7009
    nlaudico@theruthgroup.com
    rpellegrino@theruthgroup.com

    Media:
    Jason Rando
    The Ruth Group
    (646) 536-7025
    jrando@theruthgroup.com

SOURCE Symmetry Medical Inc.


'/>"/>
SOURCE Symmetry Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Symmetry Medical to Present at 21st Annual Piper Jaffray Health Care Conference
2. Symmetry Medical Reports Third Quarter 2009 Financial Results
3. Symmetry Medical Updates Full Year 2009 Financial Guidance
4. Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009
5. Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research
6. Cantel Medical Authorizes Semiannual Dividend
7. Connectyx Announces Distribution Partnership with United States Medical Supply
8. Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment
9. First Patient Treated in Clinical Study of Cohera Medicals TissuGlu(R) Surgical Adhesive
10. Greenway Medical Technologies PrimeSuite Wins Three Best in KLAS Awards
11. Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... -- Tempus, a technology company focused on helping ... Cancer Center have joined together to improve research ... analysis and clinical decision support tools available to ... As part of the new collaboration, ... analysis for ovarian and triple negative breast cancer ...
(Date:1/17/2017)... Catherine Amey ; ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... Neurological Review , the ... reports that despite standard care, temperatures exceeding 37.5°C ...
(Date:1/17/2017)... Md. , Jan. 17, 2017  CSSi, the ... for the clinical research industry, will exhibit at the ... Operations Executives (SCOPE 2017), taking place from Tuesday, January ... Regency Miami in Miami, FL. ... newest proprietary technology platform, SmartStudy™ EMR, which provides a ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... ... partnership with Sigfox in the U.S.A. to offer Internet of Things ... new offerings on large-scale environmental sensor deployments such as monitoring solutions used to ...
(Date:1/17/2017)... Baltimore, MD (PRWEB) , ... January 17, 2017 , ... ... joined the firm as a Principal in its IT Advisory Services practice . ... in recent months as market demand for strategic IT guidance grows, and the practice ...
(Date:1/17/2017)... ... January 17, 2017 , ... Physicians Education ... Lee as keynote speaker for the 34th Annual Miami Breast Cancer Conference®, on ... announcement, PER® president, Phil Talamo, said, “We are delighted to have Sandra Lee ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Many people make New Year’s resolutions or ... Robert Mondavi is making it easier for people who want to kick off 2017 ... new and existing patients. , These special offers include: , , ...
(Date:1/16/2017)... ... January 17, 2017 , ... To provide comfort and fuel ... the fast-casual category, announces a hearty and wholesome Winter Menu. Starting today, guests ... Mash-Up Sandwich, Cranberry Crunch & Honey Parfait, Slow Cooked Smoky Chicken & Sausage ...
Breaking Medicine News(10 mins):